BioCorRx Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was USD 0.094441 million compared to USD 0.008817 million a year ago. Net loss was USD 0.949118 million compared to USD 1.36 million a year ago. Basic loss per share from continuing operations was USD 0.13 compared to USD 0.21 a year ago.
For the nine months, sales was USD 0.130961 million compared to USD 0.034659 million a year ago. Net loss was USD 3.21 million compared to USD 4.01 million a year ago. Basic loss per share from continuing operations was USD 0.46 compared to USD 0.62 a year ago.